WorkBoat Header Background Image

WorkBoat+ Membership – Free to Join

Now Available: The U.S. Dredge Report 2025 — download today for expert dredging market insights and data → Click Here

Workboat Indexes

Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Workboat Indexes
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

9.910 +0.490 (+5.20%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 14, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Bioventus Reports Third Quarter Results; Updates Full-Year 2022 Financial Guidance
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Report Third Quarter of Fiscal Year 2022 Financial Results on November 8, 2022
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus to Showcase Full Orthobiologics and Ultrasonic Portfolio at NASS in Chicago
Full Launch of BoneScalpel® Access™ at NASS 
From Bioventus, Inc.
Via GlobeNewswire
News headline image
Bioventus: Q2 Earnings Insights ↗
  Bioventus (NASDAQ:BVS) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Bioventus: Q1 Earnings Insights ↗
Bioventus (NASDAQ:BVS) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
News headline image
Bioventus: Q4 Earnings Insights ↗
Bioventus (NASDAQ:BVS) reported its Q4 earnings results on Thursday, March 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings... 
Via Benzinga
News headline image
Twitter Shares Surge Around 8%, Here's 66 Biggest Movers From Yesterday ↗
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares climbed 71.1% to close at $5.20. Qurate Retail will host a conference call to discuss Q2 results on Friday, August 5th. 
Via Benzinga
News headline image
Bioventus's Return On Capital Employed Insights ↗
Bioventus (NASDAQ:BVS) brought in sales totaling $117.29 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 682.14%, resulting in a loss of $14.81 million. 
Via Benzinga
News headline image
Earnings Scheduled For March 10, 2022 ↗
Companies Reporting Before The Bell • Despegar.com (NYSE:DESP) is expected to report quarterly loss at $0.08 per share on revenue of $110.93 million. • ProShares... 
Via Benzinga
News headline image
Earnings Scheduled For August 10, 2021 ↗
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
On Monday, 78 companies set new 52-week lows. Key Facts About Today's 52-Week Lows: Citigroup (NYSE:C) was the biggest company by market cap to set a new 52-week low.... 
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For March 15, 2022 ↗
Upgrades For Turquoise Hill Resources Ltd (NYSE:TRQ), BMO Capital upgraded the previous rating of Underperform to Market Perform. Turquoise Hill Resources earned $0.78 in the... 
Via Benzinga
News headline image
Bioventus Posts Q4 Profit Ahead Of Consensus, Forecasts FY22 Sales Jump Of ~30% ↗
Bioventus Inc's (NASDAQ: BVS) Q4 FY21 sales increased 32.3% Y/Y (5.1% organically) to $130.4 million, almost in line with the consensus of $130.3 million. Sales... 
Via Benzinga
News headline image
Bioventus Inc. (BVS) Q3 2021 Earnings Call Transcript ↗
BVS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Will a Powerful Acquisition Make This Early 2021 IPO a Buy? ↗
Maybe the equivalent of an extra full quarter of revenue will get the attention of investors. 
Via The Motley Fool
Topics Initial Public Offering
News headline image
Bioventus Inc. (BVS) Q2 2021 Earnings Call Transcript ↗
BVS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Bioventus Scoops Up Misonix In $518M Stock & Cash Deal; Raises FY21 Sales Outlook ↗
Recently listed Bioventus Inc (NASDAQ: BVS) has agreed to acquire Misonix Inc (NASDAQ: MSON) for $518 million in a cash-and-stock transaction. Misonix... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 1, 2021 ↗
Upgrades Citigroup upgraded the previous rating for Thor Industries Inc (NYSE: 
Via Benzinga
News headline image
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
Earnings Scheduled For May 12, 2021 ↗
Companies Reporting Before The Bell • PolyPid (NASDAQ:PYPD) is estimated to report earnings for its first quarter. • Boyd Gaming (NYSE:BYD) is projected to report... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Privacy Policy DSAR Requests Terms of Use Locations Events, Products & Services
© 2026 Diversified Communications. All rights reserved.